Living with Eczema: What People Don’t See - Patient Webinar

Schedule

Time	Session
18:00	Welcome & introduction — Chair, Dr Satveer Mahil
18:05	Understanding Disease Burden: Our Approach in the BEACON Trial — Dr Andrew Pink & Jane Harvey
18:15	Mind & Skin: The Link Between Skin Inflammation and the Nervous System in Eczema — Professor Carsten Flohr
18:35	Panel Q&A — Jane Harvey, Professor Carsten Flohr, Dr Mark Turner, Dr Satveer Mahil
18:58	Close

You'll be able to submit your questions live via the Zoom Q&A function or over facebook.

---

Our speakers:

Dr Satveer Mahil (Chair)

Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust

Dr Satveer Mahil is a Consultant Dermatologist at St John's Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and Reader at King's College London. She graduated from the University of Cambridge and completed integrated academic training (NIHR Academic Clinical Fellowship and NIHR Clinical Lectureship) in Dermatology at St John's Institute of Dermatology. During her MRC-funded PhD, she used genetic information to gain novel insights into the mechanistic basis of different forms of psoriasis and define new therapeutic targets. After her PhD, she was awarded an MRC Clinical Academic Research Partnership Award and she currently holds an NIHR Advanced Fellowship. Her translational research seeks to optimise outcomes for individuals with inflammatory skin diseases including psoriasis and eczema. She is director of St John's DermAcademy (dermatology education academy).

---

Dr Andrew Pink

Consultant Dermatologist and Director of Adult Clinical Trials Unit; St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust; Adjunct Reader, King’s College London

Andrew is a consultant dermatologist and the director of the adult clinical trials unit at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals, London. He is an Adjunct Reader in clinical and therapeutic dermatology at King’s College London and deputy director of the NIHR South London Commercial Research Delivery Centre (CRDC) based out of Guy's & St. Thomas' Hospitals. Andrew is a councillor in the International Psoriasis Council and International Eczema Council, Chair of the Annual UK Dermatology Course for Consultants, Associate Editor of the clinical trials section of the British Journal of Dermatology (BJD), Co-Chair of the international Psoriasis: Gene to Clinic conference, ex-Honorary Secretary of the St John’s Dermatological Society and regularly acts as a NICE clinical expert. His clinical and academic interests focus on inflammatory skin disease and translational medicine, primarily in eczema and psoriasis. Andrew helped to develop and leads a national multi-disciplinary eczema service and a large and very active trials unit (phase II-IV) at St. John’s. He has acted as CI on multiple trials examining novel therapies emerging in psoriasis, eczema and prurigo nodularis and is Chief Investigator for the BEACON trial, the first global multi-arm multi-stage platform trial in atopic eczema (www.beacontrial.org).

---

Dr Jane Harvey

Research Fellow, Faculty of Medicine & Health Sciences - Nottingham University

Dr Jane Harvey is a researcher at the University of Nottingham with an interest in the management of eczema and other dermatological conditions. Jane has experience of interviewing patients and health care professionals on a diverse range of topics including attitudes towards taking medicines, the treatment of dermatological conditions within community pharmacy and experiences of accessing services through community pharmacy. Jane has also worked on several Cochrane Systematic Reviews evaluating the treatments used in the management of eczema and is currently working on the BEACON trial, where she has been interviewing participants to understand their experiences of using systemic treatments for moderate to severe eczema.

Jane is also a registered pharmacist, having experience over the last 15 years in both primary and secondary care.

---

Professor Carsten Flohr

MA MPhil MSc DHSR DLSHTM PhD FRCP FRCPCH; St. John’s Institute of Dermatology; Guy’s & St Thomas’ Hospitals and King’s College London

Professor Flohr holds the Chair in Dermatology and Population Health Science at St John’s Institute of Dermatology, King’s College London. He is also Consultant Dermatologist and R&D Lead at Guy’s & St Thomas’ NHS Foundation Trust.

Carsten was the first UK National Institute for Health Research (NIHR) Clinician Scientist in Dermatology (2009-2014) and the first UK dermatologist to be awarded a Career Development Fellowship from the NIHR (2014-2019). He has a particular interest in novel methods of atopic dermatitis (AD) prevention (early life risk factors), the role of the microbiome in AD, how AD links in with food allergies (transcutaneous sensitisation) and therapeutics, especially in severe AD.

Carsten Flohr co-led the landmark Enquiring About Tolerance (EAT) trial and was Chief Investigator of the TREatment of severe eczema in children Trial (TREAT), funded by the UK Department of Health, which compared cyclosporine with methotrexate in children with recalcitrant AD. He leads the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR), as well as the European Dream-To-Treat-AD project, which brings together 5 European atopic dermatitis systemic therapy registers. In addition, Professor Flohr’s department investigates how food allergies develop through the skin, together with collaborators from Germany and France in the EU H2020-funded Trans-Foods consortium. He also directs the Global Atopic Dermatitis Atlas (GADA) project.

Prof Flohr is a Founding Director of the International Eczema Council and Past President of the British Society of Paediatric Dermatology, as well as an Honorary Member of the French Society of Dermatology and Venereology.

---

Dr Mark Turner

Clinical Psychologist, St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust

Mark Turner completed his doctorate degree in clinical psychology at the Institute of Psychiatry, King’s College London (KCL) in October 2012. After graduating, he gained experience working in a primary care psychology service. Since February 2014 he has been working full-time with medical dermatology multidisciplinary teams in order to develop “stepped-care” psychological support in clinics for patients with a range of skin conditions including psoriasis, eczema, hidradenitis suppurativa (HS), vitiligo, and others at Guy’s and St Thomas’s NHS Foundation Trust (GSTT). He works in medical dermatology clinics alongside nursing and medical colleagues and also provides psychological assessment and therapy in his own psychology clinics. His therapeutic work with patients applies Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), Eye Movement Desensitization and Re-Processing (EMDR), Habit Reversal, and Mindfulness, to support their holistic care. He also works with colleagues to provide joint psychiatry and psychology training to dermatology nursing and medical staff and offers clinical supervision to other psychologists. Mark has occasional lecturing duties for KCL. He is also collaborating with his colleagues in medical dermatology and the health psychology section of KCL on research projects, one of which focuses on the role of illness perceptions in outcomes in HS. He was also a member of the working group for the recent All Party Parliamentary Group on Skin report “Mental Health and Skin Disease” (2020).

---